glp 1 agonists mechanism of action GLP-1 Receptor as Treatments for Type 2 Diabetes Evolution of GLP‐1 Receptor Agonists
Description
doi: 10.1038/s41467-024-48780-6
( Epub 20231228 )
In cases where an employer is providing plan coverage for GLP-1 medications for obesity, there are risks and potential unforeseen consequences if the coverage doesnt have a defined plan structure and a managed process for treatment
This trial was important because a significant clinical benefit was seen in a lower-risk patient population irrespective of baseline cardiovascular risk
p = 0.003)
